Health
Johnson & Johnson COVID-19 vaccine linked to potentially paralysing Guillain-Barré syndrome – 7NEWS.com.au
Just weeks ago, the TGA granted the vaccine provisional approval for use in Australia.
There are fears some recipients of Johnson & Johnsons coronavirus vaccine face an increased risk of a rare neurological complication known as Guillain-Barre syndrome (GBS) after an increase in reports of the sometimes paralysing condition.
The US Food and…
Continue Reading
-
Noosa News18 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Noosa News19 hours agoForum responds to urgent homelessness issues in Nambour
-
Business16 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General18 hours agoEnergy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers